
Christopher W. Fulton
Examiner (ID: 16699, Phone: (571)272-2242 , Office: P/2855 )
| Most Active Art Unit | 2855 |
| Art Unit(s) | 2859, 3641, 2406, 2899, 2841, 2855, 3108, 2856 |
| Total Applications | 3373 |
| Issued Applications | 2875 |
| Pending Applications | 85 |
| Abandoned Applications | 419 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5817624
[patent_doc_number] => 20060021937
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-02
[patent_title] => 'Methods for removing suspended particles from soluble protein solutions'
[patent_app_type] => utility
[patent_app_number] => 10/698230
[patent_app_country] => US
[patent_app_date] => 2003-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5845
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20060021937.pdf
[firstpage_image] =>[orig_patent_app_number] => 10698230
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/698230 | Methods for removing suspended particles from soluble protein solutions | Oct 30, 2003 | Abandoned |
Array
(
[id] => 5620005
[patent_doc_number] => 20060189539
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-24
[patent_title] => 'Novel GnRH analogues with antitumour effects and pharmaceutical compositions thereof'
[patent_app_type] => utility
[patent_app_number] => 10/695382
[patent_app_country] => US
[patent_app_date] => 2003-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19899
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0189/20060189539.pdf
[firstpage_image] =>[orig_patent_app_number] => 10695382
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/695382 | Novel GnRH analogues with antitumour effects and pharmaceutical compositions thereof | Oct 27, 2003 | Abandoned |
Array
(
[id] => 524076
[patent_doc_number] => 07186859
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-03-06
[patent_title] => 'Uses for amino acid anticonvulsants'
[patent_app_type] => utility
[patent_app_number] => 10/688709
[patent_app_country] => US
[patent_app_date] => 2003-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14777
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/186/07186859.pdf
[firstpage_image] =>[orig_patent_app_number] => 10688709
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/688709 | Uses for amino acid anticonvulsants | Oct 16, 2003 | Issued |
Array
(
[id] => 7474000
[patent_doc_number] => 20040097416
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-20
[patent_title] => 'New uses for amino acid anticonvulsants'
[patent_app_type] => new
[patent_app_number] => 10/688638
[patent_app_country] => US
[patent_app_date] => 2003-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15086
[patent_no_of_claims] => 72
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0097/20040097416.pdf
[firstpage_image] =>[orig_patent_app_number] => 10688638
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/688638 | Uses for amino acid anticonvulsants | Oct 16, 2003 | Issued |
Array
(
[id] => 5700611
[patent_doc_number] => 20060217296
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-28
[patent_title] => 'Use of ghrelin for treating malnutrition in gastrectomized individuals'
[patent_app_type] => utility
[patent_app_number] => 10/530866
[patent_app_country] => US
[patent_app_date] => 2003-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 16896
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0217/20060217296.pdf
[firstpage_image] =>[orig_patent_app_number] => 10530866
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/530866 | Use of ghrelin for treating malnutrition in gastrectomized individuals | Oct 8, 2003 | Issued |
Array
(
[id] => 5887432
[patent_doc_number] => 20060275213
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-07
[patent_title] => 'Tumor targeting agents and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/530024
[patent_app_country] => US
[patent_app_date] => 2003-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27488
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20060275213.pdf
[firstpage_image] =>[orig_patent_app_number] => 10530024
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/530024 | Tumor targeting agents and uses thereof | Oct 2, 2003 | Abandoned |
Array
(
[id] => 5624789
[patent_doc_number] => 20060263294
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-23
[patent_title] => 'Tumor targeting agents and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/530016
[patent_app_country] => US
[patent_app_date] => 2003-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 26325
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0263/20060263294.pdf
[firstpage_image] =>[orig_patent_app_number] => 10530016
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/530016 | Tumor targeting agents and uses thereof | Oct 2, 2003 | Abandoned |
Array
(
[id] => 483637
[patent_doc_number] => 07220827
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-05-22
[patent_title] => 'Compound binding to leukocytes and medicinal composition containing the compound in labeled state as the active ingredient'
[patent_app_type] => utility
[patent_app_number] => 10/528771
[patent_app_country] => US
[patent_app_date] => 2003-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 30
[patent_no_of_words] => 26136
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/220/07220827.pdf
[firstpage_image] =>[orig_patent_app_number] => 10528771
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/528771 | Compound binding to leukocytes and medicinal composition containing the compound in labeled state as the active ingredient | Sep 25, 2003 | Issued |
Array
(
[id] => 7281235
[patent_doc_number] => 20040063612
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-01
[patent_title] => 'Neuroprotective agents'
[patent_app_type] => new
[patent_app_number] => 10/672257
[patent_app_country] => US
[patent_app_date] => 2003-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11010
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20040063612.pdf
[firstpage_image] =>[orig_patent_app_number] => 10672257
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/672257 | Neuroprotective agents | Sep 25, 2003 | Abandoned |
Array
(
[id] => 7224386
[patent_doc_number] => 20040072737
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-15
[patent_title] => 'Echinocandin derivatives, their method of preparation and their application as anti-fungal agents'
[patent_app_type] => new
[patent_app_number] => 10/666072
[patent_app_country] => US
[patent_app_date] => 2003-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5698
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0072/20040072737.pdf
[firstpage_image] =>[orig_patent_app_number] => 10666072
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/666072 | Echinocandin derivatives, their method of preparation and their application as anti-fungal agents | Sep 18, 2003 | Issued |
Array
(
[id] => 307556
[patent_doc_number] => 07531622
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-05-12
[patent_title] => 'Synthesis and characterization of novel systems for guidance and vectorization of molecules of therapeutic interest towards target cells'
[patent_app_type] => utility
[patent_app_number] => 10/528320
[patent_app_country] => US
[patent_app_date] => 2003-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 5241
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 177
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/531/07531622.pdf
[firstpage_image] =>[orig_patent_app_number] => 10528320
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/528320 | Synthesis and characterization of novel systems for guidance and vectorization of molecules of therapeutic interest towards target cells | Sep 18, 2003 | Issued |
Array
(
[id] => 5844263
[patent_doc_number] => 20060122095
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-08
[patent_title] => 'Mucus formulation for mucosal surfaces and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/527690
[patent_app_country] => US
[patent_app_date] => 2003-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9053
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20060122095.pdf
[firstpage_image] =>[orig_patent_app_number] => 10527690
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/527690 | Mucus formulation for mucosal surfaces and uses thereof | Sep 11, 2003 | Abandoned |
Array
(
[id] => 7270359
[patent_doc_number] => 20040058877
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-25
[patent_title] => 'Somatostatin antagonists and agonists that act at the sst subtype 2 receptor'
[patent_app_type] => new
[patent_app_number] => 10/658230
[patent_app_country] => US
[patent_app_date] => 2003-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14758
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20040058877.pdf
[firstpage_image] =>[orig_patent_app_number] => 10658230
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/658230 | Somatostatin antagonists and agonists that act at the sst subtype 2 receptor | Sep 7, 2003 | Abandoned |
Array
(
[id] => 7473657
[patent_doc_number] => 20040121941
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-24
[patent_title] => 'Novel inhibitors of prenylated pyrophosphate consuming enzymes'
[patent_app_type] => new
[patent_app_number] => 10/653069
[patent_app_country] => US
[patent_app_date] => 2003-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4226
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0121/20040121941.pdf
[firstpage_image] =>[orig_patent_app_number] => 10653069
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/653069 | Novel inhibitors of prenylated pyrophosphate consuming enzymes | Sep 2, 2003 | Abandoned |
Array
(
[id] => 7136004
[patent_doc_number] => 20040043934
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-04
[patent_title] => 'Synthetic peptides that inhibit leukocyte superoxide anion production and/or attract leukocytes'
[patent_app_type] => new
[patent_app_number] => 10/651147
[patent_app_country] => US
[patent_app_date] => 2003-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 8808
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0043/20040043934.pdf
[firstpage_image] =>[orig_patent_app_number] => 10651147
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/651147 | Synthetic peptides that inhibit leukocyte superoxide anion production and/or attract leukocytes | Aug 27, 2003 | Abandoned |
Array
(
[id] => 7136018
[patent_doc_number] => 20040043939
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-04
[patent_title] => 'Peptide-based gemini compounds'
[patent_app_type] => new
[patent_app_number] => 10/647639
[patent_app_country] => US
[patent_app_date] => 2003-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8740
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0043/20040043939.pdf
[firstpage_image] =>[orig_patent_app_number] => 10647639
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/647639 | Peptide-based gemini compounds | Aug 24, 2003 | Abandoned |
Array
(
[id] => 7297212
[patent_doc_number] => 20040214765
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-28
[patent_title] => 'Methods and means for inhibition of CDK4 activity'
[patent_app_type] => new
[patent_app_number] => 10/646267
[patent_app_country] => US
[patent_app_date] => 2003-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 19232
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20040214765.pdf
[firstpage_image] =>[orig_patent_app_number] => 10646267
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/646267 | Methods and means for inhibition of CDK4 activity | Aug 21, 2003 | Abandoned |
Array
(
[id] => 383111
[patent_doc_number] => 07307063
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-12-11
[patent_title] => 'Melanocortin metallopeptides for treatment of sexual dysfunction'
[patent_app_type] => utility
[patent_app_number] => 10/640755
[patent_app_country] => US
[patent_app_date] => 2003-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 15006
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/307/07307063.pdf
[firstpage_image] =>[orig_patent_app_number] => 10640755
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/640755 | Melanocortin metallopeptides for treatment of sexual dysfunction | Aug 12, 2003 | Issued |
Array
(
[id] => 6971237
[patent_doc_number] => 20050036947
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-17
[patent_title] => 'Target-specific activatable polymeric imaging agents'
[patent_app_type] => utility
[patent_app_number] => 10/638888
[patent_app_country] => US
[patent_app_date] => 2003-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8777
[patent_no_of_claims] => 66
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0036/20050036947.pdf
[firstpage_image] =>[orig_patent_app_number] => 10638888
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/638888 | Target-specific activatable polymeric imaging agents | Aug 11, 2003 | Abandoned |
Array
(
[id] => 4575003
[patent_doc_number] => 07833532
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-11-16
[patent_title] => 'Immunogenic lipopeptides comprising T-helper and cytotoxic T lymphocyte (CTL) epitopes'
[patent_app_type] => utility
[patent_app_number] => 10/524936
[patent_app_country] => US
[patent_app_date] => 2003-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 18
[patent_no_of_words] => 27000
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/833/07833532.pdf
[firstpage_image] =>[orig_patent_app_number] => 10524936
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/524936 | Immunogenic lipopeptides comprising T-helper and cytotoxic T lymphocyte (CTL) epitopes | Aug 11, 2003 | Issued |